We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cellectricon Establishes Scientific Advisory Board to Enhance Its Pain and CNS Discovery Services

News   Jul 09, 2015

 
Cellectricon Establishes Scientific Advisory Board to Enhance Its Pain and CNS Discovery Services
 
 
 

RELATED ARTICLES

Harnessing AI to Improve Drug Combination Design

News

Artificial intelligence is having a positive impact on drug development and personalized medicine. With the ability to efficiently analyze small datasets that focus on the specific disease of interest, small dataset-based AI platforms can rationally design optimal drug combinations that are effective and based on real experimental data and not mechanistic assumptions or predictive modeling.

READ MORE

Mouse Study Reverses Sensory Impairment in Autism Model

News

Genetic technique is a step toward strategy to help people with autism better process visual cues

READ MORE

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE